Advances and challenges in the treatment of esophageal cancer
Esophageal cancer (EC) is one of the most common cancers with high morbidity and mortality rates. EC includes two histological subtypes, namely esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC). ESCC primarily occurs in East Asia, whereas EAC occurs in Western countries....
Enregistré dans:
Auteurs principaux: | Shiming He, Jian Xu, Xiujun Liu, Yongsu Zhen |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9eca37b54fe44c4b85dd7c58d9a19ab3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cost-Effectiveness Analysis of Camrelizumab Versus Chemotherapy as Second-Line Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma
par: Hongfu Cai, et autres
Publié: (2021) -
Predicting the Prognosis of Esophageal Adenocarcinoma by a Pyroptosis-Related Gene Signature
par: Ruijie Zeng, et autres
Publié: (2021) -
Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
par: Zongdan Jiang, et autres
Publié: (2021) -
3D Organoids: An Untapped Platform for Studying Host–Microbiome Interactions in Esophageal Cancers
par: Samuel Flashner, et autres
Publié: (2021) -
Esophageal cancer principles and practice /
Publié: (2009)